Animal models of leptospirosis: Of mice and hamsters

Frontiers in Immunology

Volumn 8, Issue FEB, 2017, Pages

  Gomes Solecki, Maria ^a   Santecchia, Ignacio ^b,c   Werts, Catherine ^b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

Author keywords

Animal models; Hamsters; Leptospira interrogans; Leptospirosis; Mouse models; TLR2; TLR4; Virulence factors

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; EXPERIMENTAL MODEL; FLAGELLUM; GENETIC POLYMORPHISM; GERBIL MODEL; GUINEA PIG; HAMSTER; IMMUNE RESPONSE; LEPTOSPIROSIS; LIFE CYCLE STAGE; MACROPHAGE; MICROBIAL COLONIZATION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SYSTEMATIC REVIEW (TOPIC); ZOONOSIS;

EID: 85014323712     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00058     Document Type: Review

References (125)

1. Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol (2009) 7(10):736-47. doi:10.1038/nrmicro2208
2. Haake DA, Levett PN. Leptospirosis in humans. Curr Top Microbiol Immunol (2015) 387:65-97. doi:10.1007/978-3-662-45059-8_5
3. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis (2015) 9(9):e0003898. doi:10.1371/journal.pntd.0003898
4. Athanazio DA, Silva EF, Santos CS, Rocha GM, Vannier-Santos MA, McBride AJ, et al. Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop (2008) 105(2):176-80. doi:10.1016/j.actatropica.2007.10.012
5. Rajapakse S, Rodrigo C, Haniffa R. Developing a clinically relevant classification to predict mortality in severe leptospirosis. J Emerg Trauma Shock (2010) 3(3):213-9. doi:10.4103/0974-2700.66519
6. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet (1999) 354(9181):820-5. doi:10.1016/S0140-6736(99)80012-9
7. Harrison NA, Fitzgerald WR. Leptospirosis-can it be a sexually transmitted disease? Postgrad Med J (1988) 64(748):163-4. doi:10.1136/pgmj.64.748.163
8. Bolin CA, Koellner P. Human-to-human transmission of Leptospira interrogans by milk. J Infect Dis (1988) 158(1):246-7. doi:10.1093/infdis/158.1.246
9. Ganoza CA, Matthias MA, Saito M, Cespedes M, Gotuzzo E, Vinetz JM. Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl Trop Dis (2010) 4(2):e612. doi:10.1371/journal.pntd.0000612
10. Inada R, Ido Y, Hoki R, Kaneko R, Ito H. The etiology, mode of infection, and specific therapy of weil's disease (spirochaetosis icterohaemorrhagica). J Exp Med (1916) 23(3):377-402. doi:10.1084/jem.23.3.377
11. Morton HE. Susceptibility of Syrian hamsters to leptospirosis. Proc Soc Exp Biol Med (New York, NY) (1942) 49:566-8. doi:10.3181/00379727-49-13630
12. Brunner KT, Meyer KF. Streptomycin in the treatment of Leptospira carriers; experiments with hamsters and dogs. Proc Soc Exp Biol Med (1949) 70(3):450-2. doi:10.3181/00379727-70-16957
13. Miller NG, Allen JE, Wilson RB. The pathogenesis of hemorrhage in the lung of the hamster during acute leptospirosis. Med Microbiol Immunol (1974) 160(4):269-78. doi:10.1007/BF02121442
14. Miller NG, Wilson RB. Electron microscopy of the liver of the hamster during acute and chronic leptospirosis. Am J Vet Res (1966) 27(119):1071-81.
15. De Brito T, Bohm GM, Yasuda PH. Vascular damage in acute experimental leptospirosis of the guinea-pig. J Pathol (1979) 128(4):177-82. doi:10.1002/path.1711280403
16. Imamura S, Ashizawa Y, Nagata Y. Studies on leptospirosis. I. Experimental leptospirosis of mice with jaundice, hemorrhage and high mortality. Jpn J Exp Med (1960) 30:427-31.
17. Neghme A, Christen R, Jarpa A, Agosin M. [Studies on immunobiology of parasitic diseases. II. Susceptibility of pure strains of mice to experimental leptospirosis]. Bol Inf Parasit Chil (1951) 6(1):4-5.
18. Emanuel ML, Mackerras IM, Smith DJ. The epidemiology of leptospirosis in North Queensland. I. General surgery of animal hosts. J Hyg (1964) 62:451-84. doi:10.1017/S0022172400040195
19. Spradbrow PB. Chemotherapy of experimental leptospiral infection in mice. Br J Pharmacol Chemother (1963) 20:237-44. doi:10.1111/j.1476-5381.1963.tb01463.x
20. Kobayashi Y. Clinical observation and treatment of leptospirosis. J Infect Chemother (2001) 7(2):59-68. doi:10.1007/s1015610070059
21. van den Ingh TS, Hartman EG. Pathology of acute Leptospira interrogans serotype Icterohaemorrhagiae infection in the Syrian hamster. Vet Microbiol (1986) 12(4):367-76. doi:10.1016/0378-1135(86)90086-6
22. Miyahara S, Saito M, Kanemaru T, Villanueva SY, Gloriani NG, Yoshida S. Destruction of the hepatocyte junction by intercellular invasion of Leptospira causes jaundice in a hamster model of Weil's disease. Int J Exp Pathol (2014) 95(4):271-81. doi:10.1111/iep.12085
23. Haake DA. Hamster model of leptospirosis. Curr Protoc Microbiol (2006) 12(12E):2. doi:10.1002/9780471729259.mc12e02s02
24. Vernel-Pauillac F, Merien F. Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun (2006) 74(7):4172-9. doi:10.1128/IAI.00447-06
25. Vernel-Pauillac F, Goarant C. Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. PLoS Negl Trop Dis (2010) 4(1):e582. doi:10.1371/journal.pntd.0000582
26. Fujita R, Koizumi N, Sugiyama H, Tomizawa R, Sato R, Ohnishi M. Comparison of bacterial burden and cytokine gene expression in golden hamsters in early phase of infection with two different strains of Leptospira interrogans. PLoS One (2015) 10(7):e0132694. doi:10.1371/journal.pone.0132694
27. Coutinho ML, Matsunaga J, Wang LC, de la Pena Moctezuma A, Lewis MS, Babbitt JT, et al. Kinetics of Leptospira interrogans infection in hamsters after intradermal and subcutaneous challenge. PLoS Negl Trop Dis (2014) 8(11):e3307. doi:10.1371/journal.pntd.0003307
28. Nally JE, Chantranuwat C, Wu XY, Fishbein MC, Pereira MM, Da Silva JJ, et al. Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol (2004) 164(3):1115-27. doi:10.1016/S0002-9440(10)63198-7
29. Yang HL, Jiang XC, Zhang XY, Li WJ, Hu BY, Zhao GP, et al. Thrombocytopenia in the experimental leptospirosis of guinea pig is not related to disseminated intravascular coagulation. BMC Infect Dis (2006) 6:19. doi:10.1186/1471-2334-6-19
30. Schuller S, Callanan JJ, Worrall S, Francey T, Schweighauser A, Kohn B, et al. Immunohistochemical detection of IgM and IgG in lung tissue of dogs with leptospiral pulmonary haemorrhage syndrome (LPHS). Comp Immunol Microbiol Infect Dis (2015) 40:47-53. doi:10.1016/j.cimid.2015.04.002
31. Packchanian A. Susceptibility and resistance of certain species of American deer mice, genus Peromyscus, and other rodents to Leptospira Icterohaemorrhagiae. U S Public health serv (1940) 55:1389-402. doi:10.2307/4583390
32. Muslich LT, Villanueva SY, Amran MY, Segawa T, Saito M, Yoshida S. Characterization of Leptospira infection in suckling and weaning rat pups. Comp Immunol Microbiol Infect Dis (2015) 38:47-55. doi:10.1016/j.cimid.2014.11.001
33. Landreth KS. Critical windows in development of the rodent immune system. Hum Exp Toxicol (2002) 21(9-10):493-8. doi:10.1191/0960327102ht287oa
34. Santos CS, Macedo JO, Bandeira M, Chagas-Junior AD, McBride AJ, McBride FW, et al. Different outcomes of experimental leptospiral infection in mouse strains with distinct genotypes. J Med Microbiol (2010) 59(Pt 9):1101-6. doi:10.1099/jmm.0.021089-0
35. Bandeira M, Santos CS, de Azevedo EC, Soares LM, Macedo JO, Marchi S, et al. Attenuated nephritis in inducible nitric oxide synthase knockout C57BL/6 mice and pulmonary hemorrhage in CB17 SCID and recombination activating gene 1 knockout C57BL/6 mice infected with Leptospira interrogans. Infect Immun (2011) 79(7):2936-40. doi:10.1128/IAI.05099-11
36. Fanton d'Andon M, Quellard N, Fernandez B, Ratet G, Lacroix-Lamande S, Vandewalle A, et al. Leptospira interrogans induces fibrosis in the mouse kidney through Inos-dependent, TLR-and NLR-independent signaling pathways. PLoS Negl Trop Dis (2014) 8(1):e2664. doi:10.1371/journal.pntd.0002664
37. Ferrer MF, Scharrig E, Alberdi L, Cedola M, Pretre G, Drut R, et al. Decay-accelerating factor 1 deficiency exacerbates leptospiral-induced murine chronic nephritis and renal fibrosis. PLoS One (2014) 9(7):e102860. doi:10.1371/journal.pone.0102860
38. Ratet G, Veyrier FJ, Fanton d'Andon M, Kammerscheit X, Nicola MA, Picardeau M, et al. Live imaging of bioluminescent Leptospira interrogans in mice reveals renal colonization as a stealth escape from the blood defenses and antibiotics. PLoS Negl Trop Dis (2014) 8(12):e3359. doi:10.1371/journal.pntd.0003359
39. Pereira MM, Andrade J, Marchevsky RS, Ribeiro dos Santos R. Morphological characterization of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar Icterohaemorrhagiae: defect of CD4+ and CD8+ T-cells are prognosticators of the disease progression. Exp Toxicol Pathol (1998) 50(3):191-8. doi:10.1016/S0940-2993(98)80083-3
40. Nally JE, Fishbein MC, Blanco DR, Lovett MA. Lethal infection of C3H/HeJ and C3H/SCID mice with an isolate of Leptospira interrogans serovar Copenhageni. Infect Immun (2005) 73(10):7014-7. doi:10.1128/IAI.73.10.7014-7017.2005
41. Richer L, Potula HH, Melo R, Vieira A, Gomes-Solecki M. Mouse model for sublethal Leptospira interrogans infection. Infect Immun (2015) 83(12):4693-700. doi:10.1128/IAI.01115-15
42. Matsui M, Roche L, Geroult S, Soupe-Gilbert ME, Monchy D, Huerre M, et al. Cytokine and chemokine expression in kidneys during chronic leptospirosis in reservoir and susceptible animal models. PLoS One (2016) 11(5):e0156084. doi:10.1371/journal.pone.0156084
43. Adler B, Faine S. Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans serovar Pomona. Infect Immun (1976) 14(3):703-8.
44. Chassin C, Picardeau M, Goujon JM, Bourhy P, Quellard N, Darche S, et al. TLR4-and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans. J Immunol (2009) 183(4):2669-77. doi:10.4049/jimmunol.0900506
45. Barnett JK, Barnett D, Bolin CA, Summers TA, Wagar EA, Cheville NF, et al. Expression and distribution of leptospiral outer membrane components during renal infection of hamsters. Infect Immun (1999) 67(2):853-61.
46. Athanazio DA, Santos CS, Santos AC, McBride FW, Reis MG. Experimental infection in tumor necrosis factor alpha receptor, interferon gamma and interleukin 4 deficient mice by pathogenic Leptospira interrogans. Acta Trop (2008) 105(1):95-8. doi:10.1016/j.actatropica.2007.09.004
47. Adler B. History of leptospirosis and Leptospira. Curr Top Microbiol Immunol (2015) 387:1-9. doi:10.1007/978-3-662-45059-8_1
48. Thiermann AB. The Norway rat as a selective chronic carrier of Leptospira Icterohaemorrhagiae. J Wildl Dis (1981) 17(1):39-43. doi:10.7589/0090-3558-17.1.39
49. Natarajaseenivasan K, Ratnam S. Experimental leptospirosis in laboratory mice and rats. J Commun Dis (1997) 29(3):291-3.
50. Tucunduva de Faria M, Athanazio DA, Goncalves Ramos EA, Silva EF, Reis MG, Ko AI. Morphological alterations in the kidney of rats with natural and experimental Leptospira infection. J Comp Pathol (2007) 137(4):231-8. doi:10.1016/j.jcpa.2007.08.001
51. Nally JE, Chow E, Fishbein MC, Blanco DR, Lovett MA. Changes in lipopolysaccharide O antigen distinguish acute versus chronic Leptospira interrogans infections. Infect Immun (2005) 73(6):3251-60. doi:10.1128/IAI.73.6.3251-3260.2005
52. Monahan AM, Callanan JJ, Nally JE. Review paper: host-pathogen interactions in the kidney during chronic leptospirosis. Vet Pathol (2009) 46(5):792-9. doi:10.1354/vp.08-VP-0265-N-REV
53. Yang CW. Leptospirosis in Taiwan-an underestimated infectious disease. Chang Gung Med J (2007) 30(2):109-15.
54. Mc IW, Montgomery GL. Renal lesions in Leptospira canicola infection in dogs. J Pathol Bacteriol (1952) 64(1):145-60. doi:10.1002/path.1700640115
55. Yang CW, Wu MS, Pan MJ, Hsieh WJ, Vandewalle A, Huang CC. The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse proximal tubule cells. J Am Soc Nephrol (2002) 13(8):2037-45. doi:10.1097/01.ASN.0000022007.91733.62
56. Ristow P, Bourhy P, Kerneis S, Schmitt C, Prevost MC, Lilenbaum W, et al. Biofilm formation by saprophytic and pathogenic leptospires. Microbiology (2008) 154(Pt 5):1309-17. doi:10.1099/mic.0.2007/014746-0
57. Chow E, Deville J, Nally J, Lovett M, Nielsen-Saines K. Prolonged Leptospira urinary shedding in a 10-year-old girl. Case Rep Pediatr (2012) 2012:169013. doi:10.1155/2012/169013
58. Inada R, Ido Y, Hoki R, Ito H, Wani H. The serum treatment of Weil's disease (spirochaetosis icterohaemorrhagica). J Exp Med (1916) 24(5):485-96. doi:10.1084/jem.24.5.485
59. Yang HY, Hung CC, Liu SH, Guo YG, Chen YC, Ko YC, et al. Overlooked risk for chronic kidney disease after leptospiral infection: a population-based survey and epidemiological cohort evidence. PLoS Negl Trop Dis (2015) 9(10):e0004105. doi:10.1371/journal.pntd.0004105
60. Zilber AL, Belli P, Grezel D, Artois M, Kodjo A, Djelouadji Z. Comparison of mucosal, subcutaneous and intraperitoneal routes of rat Leptospira infection. PLoS Negl Trop Dis (2016) 10(3):e0004569. doi:10.1371/journal.pntd.0004569
61. Zuerner RL. Host response to Leptospira infection. Curr Top Microbiol Immunol (2015) 387:223-50. doi:10.1007/978-3-662-45059-8_9
62. Adler B, Faine S, Muller HK, Green DE. Maturation of humoral immune response determines the susceptibility of guinea-pigs to leptospirosis. Pathology (1980) 12(4):529-38. doi:10.3109/00313028009086806
63. Viriyakosol S, Matthias MA, Swancutt MA, Kirkland TN, Vinetz JM. Toll-like receptor 4 protects against lethal Leptospira interrogans serovar Icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun (2006) 74(2):887-95. doi:10.1128/IAI.74.2.887-895.2006
64. Adler B, Faine S. Host immunological mechanisms in the resistance of mice to leptospiral infections. Infect Immun (1977) 17(1):67-72.
65. Lacroix-Lamande S, d'Andon MF, Michel E, Ratet G, Philpott DJ, Girardin SE, et al. Downregulation of the Na/K-ATPase pump by leptospiral glycolipoprotein activates the NLRP3 inflammasome. J Immunol (2012) 188(6):2805-14. doi:10.4049/jimmunol.1101987
66. Scharrig E, Carestia A, Ferrer MF, Cedola M, Pretre G, Drut R, et al. Neutrophil extracellular traps are involved in the innate immune response to infection with Leptospira. PLoS Negl Trop Dis (2015) 9(7):e0003927. doi:10.1371/journal.pntd.0003927
67. Pretre G, Olivera N, Cedola M, Haase S, Alberdi L, Brihuega B, et al. Role of inducible nitric oxide synthase in the pathogenesis of experimental leptospirosis. Microb Pathog (2011) 51(3):203-8. doi:10.1016/j.micpath.2011.03.011
68. Isogai E, Isogai H, Kurebayashi Y, Ito N. Biological activities of leptospiral lipopolysaccharide. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 261(1):53-64.
69. Jost BH, Adler B, Vinh T, Faine S. A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. J Med Microbiol (1986) 22(3):269-75. doi:10.1099/00222615-22-3-269
70. Challa S, Nally JE, Jones C, Sheoran AS. Passive immunization with Leptospira LPS-specific agglutinating but not non-agglutinating monoclonal antibodies protect guinea pigs from fatal pulmonary hemorrhages induced by serovar Copenhageni challenge. Vaccine (2011) 29(27):4431-4. doi:10.1016/j.vaccine.2011.04.041
71. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 282(5396):2085-8. doi:10.1126/science.282.5396.2085
72. Werts C, Tapping RI, Mathison JC, Chuang TH, Kravchenko V, Saint Girons I, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol (2001) 2(4):346-52. doi:10.1038/86354
73. Nahori MA, Fournie-Amazouz E, Que-Gewirth NS, Balloy V, Chignard M, Raetz CR, et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol (2005) 175(9):6022-31. doi:10.4049/jimmunol.175.9.6022
74. Jayaraman PA, Devlin AA, Miller JC, Scholle F. The adaptor molecule Trif contributes to murine host defense during leptospiral infection. Immunobiology (2016) 221(9):964-74. doi:10.1016/j.imbio.2016.05.006
75. Hsu SH, Lo YY, Tung JY, Ko YC, Sun YJ, Hung CC, et al. Leptospiral outer membrane lipoprotein LipL32 binding on toll-like receptor 2 of renal cells as determined with an atomic force microscope. Biochemistry (2010) 49(26):5408-17. doi:10.1021/bi100058w
76. Hung CC, Chang CT, Tian YC, Wu MS, Yu CC, Pan MJ, et al. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase. Nephrol Dial Transplant (2006) 21(4):898-910. doi:10.1093/ndt/gfi316
77. Chang MY, Cheng YC, Hsu SH, Ma TL, Chou LF, Hsu HH, et al. Leptospiral outer membrane protein LipL32 induces inflammation and kidney injury in zebrafish larvae. Sci Rep (2016) 6:27838. doi:10.1038/srep27838
78. Witchell TD, Eshghi A, Nally JE, Hof R, Boulanger MJ, Wunder EA Jr, et al. Post-translational modification of LipL32 during Leptospira interrogans infection. PLoS Negl Trop Dis (2014) 8(10):e3280. doi:10.1371/journal.pntd.0003280
79. Que-Gewirth NL, Ribeiro AA, Kalb SR, Cotter RJ, Bulach DM, Adler B, et al. A methylated phosphate group and four amide-linked acyl chains in Leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J Biol Chem (2004) 279(24):25420-9. doi:10.1074/jbc. M400598200
80. Younes-Ibrahim M, Buffin-Meyer B, Cheval L, Burth P, Castro-Faria MV, Barlet-Bas C, et al. Na, K-ATPase: a molecular target for Leptospira interrogans endotoxin. Braz J Med Biol Res (1997) 30(2):213-23. doi:10.1590/S0100-879X1997000200009
81. Werts C. Leptospirosis: a toll road from B lymphocytes. Chang Gung Med J (2010) 33(6):591-601.
82. Tu V, Adler B, Faine S. The role of macrophages in the protection of mice against leptospirosis: in vitro and in vivo studies. Pathology (1982) 14(4):463-8. doi:10.3109/00313028209092128
83. Davis JM, Haake DA, Ramakrishnan L. Leptospira interrogans stably infects zebrafish embryos, altering phagocyte behavior and homing to specific tissues. PLoS Negl Trop Dis (2009) 3(6):e463. doi:10.1371/journal.pntd.0000463
84. Fialho RN, Martins L, Pinheiro JP, Bettencourt BF, Couto AR, Santos MR, et al. Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis. Hum Immunol (2009) 70(11):915-20. doi:10.1016/j.humimm.2009.08.007
85. Esteves LM, Bulhoes SM, Branco CC, Mota FM, Paiva C, Cabral R, et al. Human leptospirosis: seroreactivity and genetic susceptibility in the population of Sao Miguel Island (Azores, Portugal). PLoS One (2014) 9(9):e108534. doi:10.1371/journal.pone.0108534
86. Cedola M, Chiani Y, Pretre G, Alberdi L, Vanasco B, Gomez RM. Association of toll-like receptor 2 Arg753Gln and toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an Argentine population. Acta Trop (2015) 146:73-80. doi:10.1016/j.actatropica.2015.03.007
87. Ristow P, Bourhy P, da Cruz McBride FW, Figueira CP, Huerre M, Ave P, et al. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog (2007) 3(7):e97. doi:10.1371/journal.ppat.0030097
88. Wunder EA, Figueira CP, Benaroudj N, Hu B, Tong BA, Trajtenberg F, et al. A novel flagellar sheath protein, FcpA, determines filament coiling, translational motility and virulence for the Leptospira spirochete. Mol Microbiol (2016) 101(3):457-70. doi:10.1111/mmi.13403
89. Fontana C, Lambert A, Benaroudj N, Gasparini D, Gorgette O, Cachet N, et al. Analysis of a spontaneous non-motile and avirulent mutant shows that FliM is required for full endoflagella assembly in Leptospira interrogans. PLoS One (2016) 11(4):e0152916. doi:10.1371/journal.pone.0152916
90. Eshghi A, Henderson J, Trent MS, Picardeau M. Leptospira interrogans lpxD homologue is required for thermal acclimatization and virulence. Infect Immun (2015) 83(11):4314-21. doi:10.1128/IAI.00897-15
91. Falkow S. Molecular Koch's postulates applied to bacterial pathogenicity-a personal recollection 15 years later. Nat Rev Microbiol (2004) 2(1):67-72. doi:10.1038/nrmicro799
92. Lambert A, Picardeau M, Haake DA, Sermswan RW, Srikram A, Adler B, et al. FlaA proteins in Leptospira interrogans are essential for motility and virulence but are not required for formation of the flagellum sheath. Infect Immun (2012) 80(6):2019-25. doi:10.1128/IAI.00131-12
93. Liao S, Sun A, Ojcius DM, Wu S, Zhao J, Yan J. Inactivation of the fliY gene encoding a flagellar motor switch protein attenuates mobility and virulence of Leptospira interrogans strain Lai. BMC Microbiol (2009) 9:253. doi:10.1186/1471-2180-9-253
94. Murray GL, Srikram A, Henry R, Hartskeerl RA, Sermswan RW, Adler B. Mutations affecting Leptospira interrogans lipopolysaccharide attenuate virulence. Mol Microbiol (2010) 78(3):701-9. doi:10.1111/j.1365-2958.2010.07360.x
95. Murray GL, Srikram A, Hoke DE, Wunder EA Jr, Henry R, Lo M, et al. Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun (2009) 77(3):952-8. doi:10.1128/IAI.01370-08
96. King AM, Bartpho T, Sermswan RW, Bulach DM, Eshghi A, Picardeau M, et al. Leptospiral outer membrane protein LipL41 is not essential for acute leptospirosis but requires a small chaperone protein, lep, for stable expression. Infect Immun (2013) 81(8):2768-76. doi:10.1128/IAI.00531-13
97. Kassegne K, Hu W, Ojcius DM, Sun D, Ge Y, Zhao J, et al. Identification of collagenase as a critical virulence factor for invasiveness and transmission of pathogenic Leptospira species. J Infect Dis (2014) 209(7):1105-15. doi:10.1093/infdis/jit659
98. Zhang L, Zhang C, Ojcius DM, Sun D, Zhao J, Lin X, et al. The mammalian cell entry (Mce) protein of pathogenic Leptospira species is responsible for RGD motif-dependent infection of cells and animals. Mol Microbiol (2012) 83(5):1006-23. doi:10.1111/j.1365-2958.2012.07985.x
99. Croda J, Figueira CP, Wunder EA Jr, Santos CS, Reis MG, Ko AI, et al. Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis. Infect Immun (2008) 76(12):5826-33. doi:10.1128/IAI.00989-08
100. Lourdault K, Matsunaga J, Haake DA. High-throughput parallel sequencing to measure fitness of Leptospira interrogans transposon insertion mutants during acute infection. PLoS Negl Trop Dis (2016) 10(11):e0005117. doi:10.1371/journal.pntd.0005117
101. Eshghi A, Becam J, Lambert A, Sismeiro O, Dillies MA, Jagla B, et al. A putative regulatory genetic locus modulates virulence in the pathogen Leptospira interrogans. Infect Immun (2014) 82(6):2542-52. doi:10.1128/IAI.01803-14
102. King AM, Pretre G, Bartpho T, Sermswan RW, Toma C, Suzuki T, et al. High-temperature protein G is an essential virulence factor of Leptospira interrogans. Infect Immun (2014) 82(3):1123-31. doi:10.1128/IAI.01546-13
103. Zhang K, Murray GL, Seemann T, Srikram A, Bartpho T, Sermswan RW, et al. Leptospiral LruA is required for virulence and modulates an interaction with mammalian apolipoprotein AI. Infect Immun (2013) 81(10):3872-9. doi:10.1128/IAI.01195-12
104. 2 and for virulence. Infect Immun (2012) 80(11):3892-9. doi:10.1128/IAI.00466-12
105. Pappas CJ, Benaroudj N, Picardeau M. A replicative plasmid vector allows efficient complementation of pathogenic Leptospira strains. Appl Environ Microbiol (2015) 81(9):3176-81. doi:10.1128/AEM.00173-15
106. Murray GL. The molecular basis of leptospiral pathogenesis. Curr Top Microbiol Immunol (2015) 387:139-85. doi:10.1007/978-3-662-45059-8_7
107. Marcsisin RA, Bartpho T, Bulach DM, Srikram A, Sermswan RW, Adler B, et al. Use of a high-throughput screen to identify Leptospira mutants unable to colonize the carrier host or cause disease in the acute model of infection. J Med Microbiol (2013) 62(Pt 10):1601-8. doi:10.1099/jmm.0.058586-0
108. Li Y, Powell DA, Shaffer SA, Rasko DA, Pelletier MR, Leszyk JD, et al. LPS remodeling is an evolved survival strategy for bacteria. Proc Natl Acad Sci U S A (2012) 109(22):8716-21. doi:10.1073/pnas.1202908109
109. Nally JE, Whitelegge JP, Bassilian S, Blanco DR, Lovett MA. Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect Immun (2007) 75(2):766-73. doi:10.1128/IAI.00741-06
110. Matsui M, Soupe ME, Becam J, Goarant C. Differential in vivo gene expression of major Leptospira proteins in resistant or susceptible animal models. Appl Environ Microbiol (2012) 78(17):6372-6. doi:10.1128/AEM.00911-12
111. Lehmann JS, Fouts DE, Haft DH, Cannella AP, Ricaldi JN, Brinkac L, et al. Pathogenomic inference of virulence-associated genes in Leptospira interrogans. PLoS Negl Trop Dis (2013) 7(10):e2468. doi:10.1371/journal.pntd.0002468
112. Agarwal N, Lamichhane G, Gupta R, Nolan S, Bishai WR. Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature (2009) 460(7251):98-102. doi:10.1038/nature08123
113. Caimano MJ, Sivasankaran SK, Allard A, Hurley D, Hokamp K, Grassmann AA, et al. A model system for studying the transcriptomic and physiological changes associated with mammalian host-adaptation by Leptospira interrogans serovar Copenhageni. PLoS Pathog (2014) 10(3):e1004004. doi:10.1371/journal.ppat.1004004
114. Bourhy P, Louvel H, Saint Girons I, Picardeau M. Random insertional mutagenesis of Leptospira interrogans, the agent of leptospirosis, using a mariner transposon. J Bacteriol (2005) 187(9):3255-8. doi:10.1128/JB.187.9.3255-3258.2005
115. Murray GL, Morel V, Cerqueira GM, Croda J, Srikram A, Henry R, et al. Genome-wide transposon mutagenesis in pathogenic Leptospira species. Infect Immun (2009) 77(2):810-6. doi:10.1128/IAI.01293-08
116. Adler B. Vaccines against leptospirosis. Curr Top Microbiol Immunol (2015) 387:251-72. doi:10.1007/978-3-662-45059-8_10
117. Zilber AL, Belli P, Artois M, Kodjo A, Djelouadji Z. First observation of Leptospira interrogans in the lungs of Rattus norvegicus. Biomed Res Int (2016) 2016:9656274. doi:10.1155/2016/9656274
118. Garcia-Monco JC, Benach JL. A disconnect between the neurospirochetoses in humans and rodent models of disease. PLoS Pathog (2013) 9(4):e1003288. doi:10.1371/journal.ppat.1003288
119. Medina C, Royo JL. Zebrafish as a model organism to study host-pathogen interactions. Methods (2013) 62(3):241-5. doi:10.1016/j.ymeth.2013.04.012
120. Kim D. Studying host-pathogen interactions and innate immunity in Caenorhabditis elegans. Dis Model Mech (2008) 1(4-5):205-8. doi:10.1242/dmm.000265
121. Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global burden of Leptospirosis: estimated in terms of disability adjusted life years. PLoS Negl Trop Dis (2015) 9(10):e0004122. doi:10.1371/journal.pntd.0004122
122. Pinto PS, Libonati H, Lilenbaum W. A systematic review of leptospirosis on dogs, pigs, and horses in Latin America. Trop Anim Health Prod (2016) 9(10):e0004122. doi:10.1007/s11250-016-1201-8
123. Xu Y, Zhu Y, Wang Y, Chang YF, Zhang Y, Jiang X, et al. Whole genome sequencing revealed host adaptation-focused genomic plasticity of pathogenic Leptospira. Sci Rep (2016) 6:20020. doi:10.1038/srep20020
124. Fouts DE, Matthias MA, Adhikarla H, Adler B, Amorim-Santos L, Berg DE, et al. What makes a bacterial species pathogenic?: comparative genomic analysis of the genus Leptospira. PLoS Negl Trop Dis (2016) 10(2):e0004403. doi:10.1371/journal.pntd.0004403
125. Patra KP, Choudhury B, Matthias MM, Baga S, Bandyopadhya K, Vinetz JM. Comparative analysis of lipopolysaccharides of pathogenic and intermediately pathogenic Leptospira species. BMC Microbiol (2015) 15:244. doi:10.1186/s12866-015-0581-7